Wikipedia

User:Bawolff/Edit COI Summary/20 per page/16

< User:Bawolff | Edit COI Summary

ADP (company)


New request to update history section (1970s–1980s)

Hello again. I'm posting another shorter History section request, this time focused only on the period from the mid-1970s to the late 1980s.

This section covers the period of rapid expansion and growth that begins with Frank Lautenberg becoming CEO in 1975 and ends with ADP's annual revenues exceeding $1 billion for the first time in the late 1980s. This period receives only a cursory treatment in the existing History section despite being arguably the most impactful era in ADP's history, as documented by numerous sources. You can see a before-and-after comparison here:

My draft also addresses the acquisitions of Time Sharing Limited and Cyphernetics currently covered in the Acquisitions section and accompanied by a citation needed tag. My draft includes reliable sourcing for both deals. As noted in one of my earlier posts here, my goal with these history drafts is to consolidate historical material from other sections and make the article easier to follow.

Once again, I hope this shorter request is easier to review & implement. Thank you! Justin at ADP (talk) 16:44, 26 June 2026 (UTC)

Chris Townsend (businessman)


Edit request

Hi, I would like to make a request for a small update to the Personal life section. I have a connection to Chris and am unable to edit the article directly, but wondered if the following might please be considered for addition after the first paragraph (my new bits are in bold and italic):

Townsend is also a Trustee and Chair of the Trading Company at the National Portrait Gallery as well as a Trustee and Chair of Digital Committee of the Royal Opera House, advising on commercial, digital and business transformation programmes and projects. Townsend is a keen conservationist and a Member of the Tusk Trust Development Board, of which Prince William, Duke of Cambridge, is the patron. Since 2026 he is a Commissioner for the Commonwealth War Graves Commission.[1]

Also, in the Education section I wondered if the fact he sits on the board might be added?

Townsend studied geography at Newcastle University, gaining a BSc Single Honours. Townsend gained an MSc in Marketing Management at Nottingham Trent University (NTU), receiving a Distinction for Dissertation and was awarded Best Student at NTU in 1998. He now sits on their board of governors.[2]

Thank you so much for considering! BadadeeBadada (talk) 16:47, 26 June 2026 (UTC)

All Out (organisation)


Edit request (COI): updated lead, History, and Organization sections

I have a conflict of interest as an employee of All Out (disclosed on my user page). Below is a first, well-sourced batch of corrections and updates. The expanded "Campaigns" section will follow as a separate request.

1. Please replace the introduction (from "All Out is a global not-for-profit organisation…" through "…Brazil, Colombia, Germany, Italy, Mexico, Kenya, Portugal, Spain, and the USA.") with:

All Out is a global LGBT rights advocacy organization that campaigns for the human rights of LGBT+ people worldwide. Founded in 2010, it is known for combining online petitions and digital organizing with offline protests, and for raising emergency funds to support local LGBT+ groups.[3][4] It is operated by two United States nonprofit entities: All Out Action Fund, Inc., a 501(c)(4) advocacy body, and All Out Impact Fund, Inc., a 501(c)(3) charity established in 2024. It is registered in New York.[5]

2. Please add a new section after the introduction:

Lee H. Roberts


Event suggestion for "During chancellorship" section

Hi editors! I am back with a request to add an event that took place on campus while Roberts was serving as interim Chancellor. This would fall under the Lee_H._Roberts#During_chancellorship section.

On Tuesday, April 30, Pro-Palestinian protesters removed the American flag from UNC-Chapel Hill's quad on Tuesday afternoon and replaced it with the Palestinian flag. Interim Chancellor Lee Roberts responded by walking out to the quad and helping to restore the U.S. flag to its position on the central campus flagpole. However, not long after the U.S. flag had been restored, a decision was made to take it back down. The flag was then folded and taken away for safekeeping, and many of the protesters who had gathered around the area dispersed.[6]

References

  1. ↑ "Our Commissioners | CWGC". CWGC. Retrieved 26 June 2026.
  2. ↑ "Chris Townsend Member of the Board of Governors". www.ntu.ac.uk. Retrieved 26 June 2026.
  3. ↑ "Gay-Rights Activists Confront Corporations On Sochi Olympic Sponsorship". Radio Free Europe/Radio Liberty. Retrieved June 17, 2026.
  4. ↑ "LGBT activists protest at FIFA Museum ahead of World Cup in Qatar". Reuters. November 8, 2022.
  5. ↑ "Financials". All Out. Retrieved June 17, 2026.
  6. ↑ Coffey, Sean; Bae, Cindy (April 30, 2024). "Pro-Palestinian protesters take down U.S. flag replace it with Palestine flag on UNC quad". ABC 11.

The purpose of this request is to add a missing event that garnered national attention. Thanks again, editors, for considering this request. AnnaUNC (talk) 18:46, 12 March 2026 (UTC)

Edit request reply 23-MAY-2026

  Edit request declined  

  • The proposed text tells only part of the story. After Roberts walked the flag out and oversaw it being placed back onto the pole, it was once again removed. According to the ABC source provided by the COI editor: "Not long after the U.S. flag had been restored, a decision was made to take it back down. This time it was folded into its traditional triangle shape and taken away for safekeeping. The flag pole on UNC's quad was then left empty and many of the protesters who had gathered around the area dispersed."
  • If the COI editor wishes, they are welcome to re-submit this request with the missing elements restored. If that be the case, kindly change the {{Edit COI}} template's answer parameter to read from |ans=y to |ans=n.

Regards,  Spintendo  17:36, 23 May 2026 (UTC)

Thank you! I just edited the request and included that information for your review. AnnaUNC (talk) 19:20, 26 June 2026 (UTC)

Colleen Hardwick


Editorializing that I argue "without evidence"

The article currently states that I oppose increases in housing supply. This is false and consequently unsupported. It states I have argued "without evidence" that density exacerbates housing affordability. "Without evidence" is the editor and source writer’s personal opinion, not a neutral fact. My positions are heavily based on data, specifically the criticisms of upzoning inflating land values without the justifying data. I also made repeated requests and motions for data from the city to justify the land upzoning push.

In the news article cited, this statement precedes the Ponzi scheme quote and provides context: “In the process of encouraging more residential development to pay for growth, she believes the use of rezoning tools and density-catalyzing area plans by consecutive City Councils has greatly exacerbated Vancouver’s housing affordability crisis by pushing land values upwards.” That is what I believe and is a fair statement.

  • Proposed fix: Please remove the false statement that I oppose increases in housing supply. Replace it with “Hardwick opposes upzoning which inflates land value.” Please remove the subjective phrase "without evidence" so the sentence is neutral. If anything, this quote fully reflected what I said: “In the process of encouraging more residential development to pay for growth, she believes the use of rezoning tools and density-catalyzing area plans by consecutive City Councils has greatly exacerbated Vancouver’s housing affordability crisis by pushing land values upwards.”
  • Sources:

Colleen Hardwick (talk) 17:07, 26 June 2026 (UTC)

Electronic Frontier Foundation


Requesting review of significantly expanded EFF article

Hi. I'm Allison and I work at EFF. The previous article about EFF was lacking key information about the last 15 years of the organization's history. I have a comprehensive rewrite that uses reliable sources to fill in the gaps and improve the overall quality of the article. You can find it here: User:AllisonEFF/sandbox.

Thank you so much for this review. AllisonEFF (talk) 21:34, 26 June 2026 (UTC)

Comment: @AllisonEFF, I appreciate the work you've put in to your rewrite, but it's extremely difficult for another editor to identify what has changed, other than doing a word-by-word comparison of two side-by-side browser tabs which is not a reasonable ask. Your version almost doubles the number of citations, each of which the reviewing editor will need to check. You're more likely to get successful updates to the article by breaking your requests down into more manageable chunks, using a change X to Y format (with the relevant sources).
Tip: you might find it useful to use Template:Text diff in your requests. Schazjmd (talk) 21:51, 26 June 2026 (UTC)
Hiya Alison!- I can take a look at your edits and review what makes sense to include! I agree with User:Schazjmd, it is much easier to review change-by-change, but I'll try to take a look at your edits and see if anything immediately stands out. pauliesnug (message / contribs) 22:03, 26 June 2026 (UTC)
[Overall diff for reference] pauliesnug (message / contribs) 22:08, 26 June 2026 (UTC)
How handy, @Pauliesnug, I didn't know about that tool. Thanks! Schazjmd (talk) 22:12, 26 June 2026 (UTC)
Of course! In this case the diff algorithm seems to have gotten a bit overwhelmed haha, but it's a pretty awesome tool. pauliesnug (message / contribs) 22:19, 26 June 2026 (UTC)
Since you're here, would you be able to contribute a freely-licensed photo of Nicole Ozer? Funcrunch (talk) 22:08, 26 June 2026 (UTC)

Changelog: Thanks for the quick replies! I have prepared a detailed xyz changelog, which shows what happens to 36 specific parts of the text from the original to the revised draft. You can see that changelog here: User:AllisonEFF/sandbox/diff. This should allow you to verify every change, including what was altered or removed and why, with sources and reasons. Take good care, AllisonEFF (talk) 17:22, 30 June 2026 (UTC)

Good work. Glancing over it, it looks fairly well researched and presented. I'll see if I can throw in some edits over the next few days to help out. I appreciate the effort. ShadowLancer (talk) 12:20, 1 July 2026 (UTC)

Walnut Creek CDROM


Narrower COI edit request about catalog range

I would like to request reconsideration of a much narrower version of my previous COI edit request. The earlier request was declined under WP:NOTCATALOG, and I understand why: it included catalog-style details such as price, ISBN, product contents, and FTP mirror information. I am no longer requesting inclusion of those details.

Disclosure: I am Robert Woeger and have a historical connection to the Bethany Bible CD-ROM. Because of that connection, I am not editing the article directly and am asking uninvolved editors to evaluate whether this narrower wording is appropriate.

Suggested placement: In the History section, after the sentence that currently mentions Simtel, CICA, Aminet, and Project Gutenberg.

Proposed text:

In addition to operating-system and software-archive releases, Walnut Creek CDROM also sold educational and topical reference collections; its Winter 1996–1997 catalog listed titles such as Project Gutenberg, Internet Info, and Bethany Bible under its educational/reference offerings.Walnut Creek CDROM Winter/1996–1997 Catalog (PDF). Walnut Creek CDROM. Winter 1996–1997. pp. 18–19. Retrieved 27 June 2026 – via KRFOSS mirror.

Reason for change: The current article already gives examples of Walnut Creek CDROM’s better-known software, operating-system, and archive publications. This single sentence is intended only to summarize the broader range of the company’s catalog, not to create a product listing or add promotional product details. I have intentionally omitted price, ISBN, contents, and mirror-directory information to address the WP:NOTCATALOG concern.

If editors still consider this undue or too catalog-like, I am fully open to leaving it out or to any more neutral wording. RobertWoeger (talk) 16:18, 27 June 2026 (UTC)

Joshua Kurlantzick


This is incorrect

He has also served as a columnist for Time, a special correspondent for The New Republic, a senior correspondent for American Prospect, and a contributing writer for Mother Jones.

This is not correct. I was a writer for the Bangkok Post, Agence France Presse, U.S. News and World Report, then the Foreign Editor of the New Republic. https://ciaotest.cc.columbia.edu/olj/fa/fa_julaug04/fa_julaug04l.html

Joshua Kurlantzick worked as a staff writer covering international economics and trade for U.S. News & World Report from January 2001 to May 2002. His reporting frequently analyzed global trade, labor disputes, and international markets. [1, 2, 3, 4] While a complete, exhaustive database of his daily 2001 dispatches is no longer maintained on a single active portal, indexed issues of the magazine from that year (such as Vol. 130) feature his coverage. To explore the archives of his articles from this period, you can access back issues through the U.S. News & World Report main portal or track his historical reporting via libraries utilizing the EBSCOhost periodical databases Jkurlant (talk) 03:00, 28 June 2026 (UTC)


  • What I think should be changed:
  • Why it should be changed:
  • References supporting the possible change (format using the "cite" button):

Jkurlant (talk) 03:04, 28 June 2026 (UTC)

References

This bio is out of date:

Joshua Kurlantzick is Senior Fellow for Southeast Asia and South Asia at the Council on Foreign Relations, not Senior Fellow for Southeast Asia: https://www.cfr.org/experts/joshua-kurlantzick

  • What I think should be changed (include citations):
  • Why it should be changed:


Jkurlant (talk) 03:06, 28 June 2026 (UTC)

References

The authorship page is badly out of date:


It reads Kurlantzick is the author of Charm Offensive: How China's Soft Power Is Transforming the World, which was nominated for the Council on Foreign Relations's 2008 Arthur Ross Book Award. In December 2022, Kurlantzick published Beijing's Global Media Offensive: China's Uneven Campaign to Influence Asia and the World. In the book, Kurlantzick analyses China's use of disinformation campaigns, state media and digital infrastructure.

This is not accurate. This is not a full list of book authorship. Here are the books published:

Charm Offensive: How China's Soft Power Is Transforming the World (2007-08) : https://yalebooks.yale.edu/book/9780300136289/charm-offensive/

The Ideal Man: The Tragedy of Jim Thompson and the American Way of War (2011) https://turnerpublishing.com/products/the-ideal-man-the-tragedy-of-jim-thompson-and-the-american-way-of-war?srsltid=AfmBOoqBOewH8hCtYVzs8t4NLXyLhtY79fEGvCJHtxejuz8k_32WT4je

Democracy in Retreat: The Revolt of the Middle Class and the Worldwide Decline in Representative Government (2013): https://yalebooks.yale.edu/book/9780300205800/democracy-in-retreat/

State Capitalism: How the Return of Statism is Transforming the World (2016): https://global.oup.com/academic/product/state-capitalism-9780199385706

A Great Place to Have a War: America in Laos and the Birth of a Military CIA (2017): https://www.simonandschuster.net/books/A-Great-Place-to-Have-a-War/Joshua-Kurlantzick/9781451667882

Beijing's Global Media Offensive: China's Uneven Campaign to Influence Asia and the World (2022): https://global.oup.com/academic/product/beijings-global-media-offensive-9780197515761?cc=us&lang=en&

Scott Herndon


Requested edits (COI).

Joshna Fernando


Factual corrections regarding photo and family

Dear Wikipedia Editors,

I am writing to formally request two corrections to the article about me, Joshna Fernando, to address recent inaccurate changes and formatting regressions.

1. Infobox Image Update: I previously uploaded a high-quality, updated profile photo of myself to Wikimedia Commons (File:Joshna Fernando Profile.jpg) under a free license. An editor reverted this back to an older image, citing an "infobox fix." I request that the current image be replaced with the updated 2024 profile image.

Please format the infobox to use the following file:

Joshna Fernando in 2024

2. Brother-in-Law Name Correction: Under the "Early life" section, it incorrectly states that my uncle is the "mother-in-law to Tamil actor Jayam Ravi." Beyond the grammatical error, the actor officially changed his screen name back to his birth name, Ravi Mohan, in January 2025.

Please update the sentence to accurately reflect his relationship and name as Ravi Mohan, and link it to his page: Ravi Mohan.

Sources verifying his name change:

Thank you for helping keep this biography accurate and compliant with BLP guidelines. ~2026-37108-90 (talk) 09:24, 28 June 2026 (UTC)

Discrete rate simulation


History

The discrete rate simulation paradigm was introduced by Andrew Siprelle in 1990 to address the limitations of conventional discrete event simulation in modeling high-speed continuous-process and bulk-flow manufacturing systems, where unit-by-unit event tracking is computationally prohibitive and dynamically inaccurate.[1] The first peer-reviewed publication of the technique appeared at the 1995 Winter Simulation Conference under the title Modeling a Bulk Manufacturing System Using Extend.[1]

The methodology was developed across a series of further Winter Simulation Conference papers through the late 1990s and early 2000s — including the 2002 Non-Item Based Discrete-Event Simulation Tools[2] — and a 2016 Springer chapter comparing it head-to-head with conventional discrete event simulation.[3] In 2020, the technique's accuracy was independently assessed in a Winter Simulation Conference paper by Tom Lange (formerly Director of Modeling and Simulation, Procter & Gamble Corporate R&D) and J. Fischel, which reported validation within 1% [[Overall equipment effectiveness|overall equipment effectiveness]] on real production lines.[4]

I have not edited the article directly. Please review and apply if appropriate. Thank you.

— Andrew Siprelle (Sir Prelle (talk) 11:59, 5 June 2026 (UTC))

  1. 1 2 Siprelle, A. J.; Parsons, D. J. (1995). "Modeling a Bulk Manufacturing System Using Extend" (PDF). Proceedings of the 1995 Winter Simulation Conference. Retrieved 2026-06-05.
  2. ↑ Phelps, R. A.; Parsons, D. J.; Siprelle, A. J. (2002). "Non-Item Based Discrete-Event Simulation Tools" (PDF). Proceedings of the 2002 Winter Simulation Conference.
  3. ↑ Comparison of Discrete Rate Modeling and Discrete Event Simulation. Springer. 2016.
  4. ↑ Lange, T.; Fischel, J. (2020). "High Accuracy Discrete Rate and Reliability Modeling to Drive Improvement of Plant OEE and Throughput" (PDF). Proceedings of the 2020 Winter Simulation Conference. Retrieved 2026-06-05.

Sir Prelle (talk) 11:59, 5 June 2026 (UTC)

Reply 24-JUN-2026

  Edit request declined  

  • As the proposed claims concern being the "originator" of this techique, we're going to require sources that are not written by the individual making the claim.

Regards,  Spintendo  06:13, 25 June 2026 (UTC)

Thank you for the review — understood, and I agree that per WP:SELFPUB a priority claim should not rest on my own publications. Below are independent, peer-reviewed sources authored by the commercial ExtendSim vendor (Imagine That Inc.), with no connection to me, that attribute the origin of the technique:
1. Damiron, C. and D. Krahl. 2014. "A Global Approach for Discrete Rate Simulation."
Proc. 2014 Winter Simulation Conference, §2.2: "The first generation DRS tool was developed in the early 1990's when it was recognized that a new simulation methodology was needed (Siprelle and Parsons 1995). Termed 'discrete rate simulation' (Siprelle et al. 1999), this new architecture utilized the discrete event clock but moved flow through the system at rates that maintained mass balance."
2. Damiron, C. and A. Nastasi. 2008. "Discrete Rate Simulation Using Linear
Programming." Proc. 2008 Winter Simulation Conference, p. 740: "The first generation DRS technology was introduced by Simulation Dynamics Inc. in 1997 (Siprelle, Phelps 1997). Taking lessons learned from this ground-breaking technology, a second generation DRS technology has now been developed and is incorporated in the Rate library of the ExtendSim AT and Suite packages."
Given these independent sources, I propose the following neutral History section, worded to track only what those sources state:
== History ==
Discrete rate simulation was developed in the early 1990s at Simulation Dynamics, Inc. by Andrew Siprelle and colleagues.[1][2] The methodology retains the discrete-event clock while moving flow through a system at rates that maintain mass balance; it was first published at the 1995 Winter Simulation Conference,[3] and the term "discrete rate simulation" was established in the authors' subsequent work.[4] The commercial ExtendSim vendor, Imagine That Inc., later described this "first generation" technology as "ground-breaking" and built a second-generation, linear-programming- based implementation upon it.[2]
[1] [2] [3] [4]
I have not edited the article directly. Please review and apply if appropriate. Thank you. — Andrew Siprelle (~~~~) Sir Prelle (talk) 19:23, 28 June 2026 (UTC)

Funding Circle


Minor page corrections from Funding Circle (CS1)

Thank you for coming back to me on the formatting requirements. I have reformatted the previous request using Citation Style 1 (CS1) as requested.

1. Chair position

Ken Stannard was appointed Chair of Funding Circle at the company's Annual General Meeting in May 2025. Ken has 30 years’ experience in credit, lending and payments, having held senior executive roles at Lloyds Banking Group, Capital One and American Express, and most recently as CEO of Cabot Credit Management.[5]

2. Partnerships section – replacing broken sources 37 and 38

In February 2024, Funding Circle formed a lending partnership with Barclays Bank and TPG Angelo Gordon, aiming to deploy up to £300 million to UK small businesses through its platform.[6]

In April 2025, Funding Circle extended its partnership with Bayview Asset Management, LLC, surpassing £1 billion in total funding.[7]

3. Further additions to partnerships section

In July 2025, Funding Circle announced a £200 million forward flow agreement with long-standing partner Deutsche Bank.[8]

In September 2025, Funding Circle announced a £300 million forward flow agreement with TPG Angelo Gordon and Barclays.[9]

In February 2026, Funding Circle announced a forward flow commitment with Waterfall Asset Management and Citi for £700 million.[10]

In April 2026, Funding Circle renewed it's £320 million funding facility for FlexiPay.[11]

4. Updated lending figures (introduction) As of 31 December 2025, Funding Circle has extended more than £17 billion in credit to over 125,000 small businesses.[12]

Many thanks again for your patience and guidance on the correct format. I hope that I've correctly understood the required style - many thanks. Abi FC (talk) 19:22, 28 June 2026 (UTC)

ARC Document Solutions


Disclosure: I have a paid conflict of interest. TLG Marketing is working on behalf of ARC / RIOT under a paid engagement. This request is intended to correct outdated factual information about ARC Document Solutions. I am not asking that maintenance templates be removed, and independent editors are welcome to modify, shorten, decline, or otherwise improve the wording below.

Requested changes:

  • Change the short description from "Republic trade company" to a neutral description such as "American document solutions company".
  • Update the lead and infobox so the article no longer describes ARC as a current publicly traded company.
  • State, with SEC sourcing, that ARC became a wholly owned subsidiary of TechPrint Holdings, LLC after the merger completed on November 22, 2024.
  • Move NYSE, IPO, ticker, and delisting information into historical context.
  • Remove active NYSE/Russell/public-company fields and active finance links that imply current public trading.
  • Update the employee count from the stale 2019 figure to the latest located pre-acquisition SEC figure, or omit the field if editors prefer not to use pre-acquisition data.
  • Remove or avoid unsupported promotional claims, including "largest company of its kind" and uncited recognition claims.
  • Keep the existing maintenance templates in place unless uninvolved editors decide otherwise.
  • Treat logo replacement as a separate issue. The current Commons logo appears to be a 2014 file, while ARC's official logo page asks users to use the current version and avoid older versions. A replacement should not be uploaded or used without a suitable license/permission path.

Main sources:

Proposed replacement wikitext:

<div class="shortdescription nomobile noexcerpt noprint searchaux" style="display:none">American document solutions company</div>
{{#parsoid


Disclosure: I have a paid conflict of interest. TLG Marketing is working on behalf of ARC / RIOT under a paid engagement.

I would like to politely request review of the logo used in the ARC Document Solutions infobox. The article currently uses the Commons file , which appears to be an older stacked lockup. ARC's current logo is shown on the company's official site here:

Related official logo page:

Requested change: if an uninvolved editor determines that the current logo can be used under the appropriate Wikipedia image policy and licensing/rationale, please replace the current infobox logo with the current ARC logo shown at the official source above. I am not uploading the file directly because I have a paid COI and understand that image licensing/non-free-use handling should be reviewed carefully. If a local non-free logo file is preferred, I defer to uninvolved editors on the correct filename, upload path, and rationale.

Thank you very much for reviewing. Lamontektlg (talk) 21:13, 5 July 2026 (UTC)


Narrow paid COI edit request: update public-company status

Disclosure: I have a paid conflict of interest. TLG Marketing is working on behalf of ARC / RIOT under a paid engagement.

This is a narrower request split from the broader request above. I am asking only for correction of current company-status language that appears to be outdated after the November 22, 2024 merger closing. I am not asking for promotional language, logo changes, service-description changes, employee-count changes, ranking/recognition additions, or removal of maintenance templates in this request.

Requested changes:

  • In the infobox, change `type = Public` to `type = Subsidiary`.
  • In the infobox, remove the current `traded_as` line showing active NYSE/Russell status, or otherwise mark the NYSE/ticker information as historical rather than current.
  • In the lead, replace the current statement that ARC "is a publicly traded company" with neutral current-status wording such as:
ARC Document Solutions, Inc. (formerly American Reprographics Company) is an American document solutions company headquartered in San Ramon, California. On November 22, 2024, TechPrint Holdings, LLC completed its acquisition of ARC, and ARC became a wholly owned subsidiary of TechPrint Holdings.<ref name="SEC8K2024">{{cite web |no-tracking=true|title=Current Report on Form 8-K |url=https://www.sec.gov/Archives/edgar/data/1305168/000114036124047571/ef20039068_8k.htm |publisher=U.S. Securities and Exchange Commission |date=November 22, 2024 |access-date=July 13, 2026}}</ref>
  • In the History section, retain the former NYSE listing only as historical context, for example:
ARC was formerly listed on the New York Stock Exchange under the ticker symbol ARC. Following completion of the TechPrint Holdings merger, NYSE trading of ARC common stock was suspended before the opening of trading on November 22, 2024, and ARC requested delisting and deregistration of its common stock.<ref name="SEC13E3A2024">{{cite web |no-tracking=true|title=Schedule 13E-3/A, Amendment No. 3 |url=https://www.sec.gov/Archives/edgar/data/1305168/000114036124047577/ef20038986_sc13e3a.htm |publisher=U.S. Securities and Exchange Commission |date=November 22, 2024 |access-date=July 13, 2026}}</ref>

Source notes:

  • The SEC Form 8-K filed November 22, 2024 states that Parent completed the acquisition, that ARC became a wholly owned subsidiary of Parent, and that ARC notified the NYSE and requested suspension, delisting, and deregistration of its common stock.
  • The SEC Schedule 13E-3/A final amendment filed November 22, 2024 states that ARC survived the merger as a wholly owned subsidiary of TechPrint Holdings, LLC, and that NYSE trading was suspended before the open on November 22, 2024.

Thank you for reviewing. Please adjust the wording as needed for neutrality, article style, or source preference. Lamontektlg (talk) 23:14, 13 July 2026 (UTC)

Transparent wood composite


COI edit request: Add Goze Mokudon as an application example with image

I have a conflict of interest regarding this topic, as I am involved in the project described below. I previously proposed a short application example, and an editor noted that an image should accompany the text. In response, I have uploaded freely licensed images to Wikimedia Commons and revised the proposed wording below.

I would like to request adding the following short implementation example to the “Applications” section, with one accompanying image.

Specific text to add:

In 2026, students at Nagaoka Institute of Design installed Goze Mokudon, a bench-shaped andon lantern incorporating transparent wood panels, in front of the Goze Museum Takada in Joetsu, Niigata Prefecture, Japan. Measuring approximately 40 cm high, 100 cm long, and 38 cm wide, the work uses LED-backlit transparent wood panels depicting Takada goze walking through a snowy gangi covered walkway.[13][14]

Suggested image:

[[File:Goze Mokudon bench-shaped andon lantern under gangi at Goze Museum Takada, Joetsu.jpg|thumb|Goze Mokudon, a bench-shaped andon lantern incorporating transparent wood panels, installed under a gangi covered walkway at the Goze Museum Takada in Joetsu, Japan.]]

Reason for the change:

This would add a sourced real-world implementation example of transparent wood in a lighting application. The suggested image addresses the previous concern that the application should be visible to readers rather than described only in text.

References:

References

  1. 1 2 Damiron, C.; Krahl, D. (2014). "A Global Approach for Discrete Rate Simulation" (PDF). Proceedings of the 2014 Winter Simulation Conference. doi:10.1109/WSC.2014.7020136.
  2. 1 2 3 Damiron, C.; Nastasi, A. (2008). "Discrete Rate Simulation Using Linear Programming" (PDF). Proceedings of the 2008 Winter Simulation Conference. doi:10.1109/WSC.2008.4736136.
  3. 1 2 Siprelle, A. J.; Parsons, D. J. (1995). "Modeling a Bulk Manufacturing System Using Extend" (PDF). Proceedings of the 1995 Winter Simulation Conference.
  4. 1 2 Siprelle, A. J.; Parsons, D. J.; Phelps, R. A. (1999). "SDI Industry Pro: Simulation for Enterprise-Wide Problem Solving" (PDF). Proceedings of the 1999 Winter Simulation Conference.
  5. ↑ "IN BRIEF: Funding Circle hires former Cabot Credit CEO to be chair". AJ Bell. 18 December 2024. Retrieved 28 June 2026.
  6. ↑ "Funding Circle announces newest lending partnership with Barclays Bank and TPG Angelo Gordon". Funding Circle. 27 February 2024. Retrieved 28 June 2026.
  7. ↑ "Funding Circle and Bayview extend funding partnership, surpassing £1 billion in total funding with J.P. Morgan and Citi backed credit facilities". Funding Circle. 15 April 2025. Retrieved 28 June 2026.
  8. ↑ "Funding Circle closes a £200 million forward flow agreement with Deutsche Bank to bolster support for UK small businesses". Funding Circle. 15 July 2025. Retrieved 28 June 2026.
  9. ↑ "Funding Circle extends strategic partnership with TPG Angelo Gordon and Barclays through £300 million forward flow deal". Funding Circle. 24 September 2025. Retrieved 28 June 2026.
  10. ↑ "Funding Circle strengthens partnership with Waterfall Asset Management through a new £700 million deal". Funding Circle. 12 February 2026. Retrieved 28 June 2026.
  11. ↑ "Funding Circle renews funding agreement to support FlexiPay growth". Funding Circle. 14 April 2026. Retrieved 28 June 2026.
  12. ↑ "Full Year 2025 Results". Funding Circle. 5 March 2026. Retrieved 28 June 2026.
  13. ↑ "ベンチ型あんどんの新作 長岡造形大の「木匠塾」寄贈 上越市 瞽女ミュージアムに設置" [New bench-shaped lantern donated by Nagaoka Institute of Design's Mokushōjuku: Installed at the Goze Museum in Joetsu City]. Joetsu Times (in Japanese). 13 May 2026.
  14. ↑ "夜の雁木通りに高田瞽女の姿浮かび上がる 上越市東本町1に「瞽女木行灯」" [Takada goze figures emerge on the night gangi arcade: "Goze Mokudon" at Higashihoncho 1, Joetsu City]. Joetsu Town Journal (in Japanese). 14 May 2026.

ArchandEng Lab (talk) 03:15, 29 June 2026 (UTC)

Focal molography


Edit request — 14 atomic changes incorporating developments 2021–2026

Hello Spintendo, thank you for the clarification. Following the Edit COI submitter instructions, I have decomposed my previous narrative request into 14 atomic edit requests below. Each contains the verbatim remove text (where applicable), verbatim add text, location, reference template, and rationale.

Disclosure: I am an employee of Miltenyi Biotec, parent company of lino Biotech AG, which commercializes focal molography. See my user page for the full COI / paid-contribution disclosure. I am refraining from editing the article directly per WP:COI and WP:PAID.

Where the same new reference is cited by more than one block, it is defined inline at first use (Blocks 2, 3, 5, 7, 9, 10) and reused thereafter via <ref name="…" />. Six new references are introduced overall; all existing references are preserved unchanged.

Block 1 — Lead: copy-edit "holography" → "focal molography"

  1. Please remove the fourth sentence of the only paragraph of the Lead section:
    "Contrary to refractometric methods for label-free biomolecular interaction analysis, such as surface plasmon resonance (SPR) and reflectometric interference spectroscopy (RIfS), holography allows quantification of molecular interactions in living cells in real time."
  2. Please add the following as the fourth sentence of the only paragraph of the Lead section:
    "Contrary to refractometric methods for label-free biomolecular interaction analysis, such as surface plasmon resonance (SPR) and reflectometric interference spectroscopy (RIfS), focal molography allows quantification of molecular interactions in living cells in real time."
  3. Reference: no new reference required (copy-edit only).
  4. Reason: The current wording reads "holography allows quantification..."; holography in general does not by itself enable this — the property is specific to focal molography. The surrounding paragraph discusses focal molography throughout. Restoring the full term aligns the sentence with the article subject.

Block 2 — Lead: add commercial-availability sentence

  1. Please remove: nothing (addition only).
  2. Please add the following as a new fifth (final) sentence of the only paragraph of the Lead section, immediately after the sentence ending "...in real time.":
    "Focal molography was developed through a collaboration between ETH Zurich and Roche from 2014 to 2020 and has been commercially available since 2024.<ref name="PRNewswire2023">"Miltenyi Biotec acquires biosensor company lino Biotech" (Press release). PR Newswire. 2023-02-22. Retrieved 2026-06-29.</ref>"
  3. Reference: defined inline above (PRNewswire2023, press release, PR Newswire, 2023-02-22).
  4. Reason: The Lead currently ends at the 2020 academic state. Per MOS:LEAD the Lead should summarise the article body. The commercialization timeline (spin-off 2020, acquisition 2023, first commercial instrument 2024) is a material development of the past six years; the press release establishes commercial availability since 2024.

Block 3 — History: add Commercialization subsection

  1. Please remove: nothing (addition only).
  2. Please add the following new subsection at the end of the History section, immediately after the existing sentence ending "...from 2014 to 2020.": 
    === Commercialization ===
In March 2020, lino Biotech AG was founded as an [[ETH Zurich]] [[university spin-off|spin-off]] in Zurich to commercialize focal molography. The company received funding from Roche Venture Fund, High-Tech Gründerfonds, and private investors.<ref name="PRNewswire2023" />

In February 2023, [[Miltenyi Biotec]], a German biotechnology company, acquired lino Biotech.<ref name="PRNewswire2023" /><ref name="BioSpace2023">{{Cite news|no-tracking=true|title=Miltenyi Biotec acquires biosensor company lino Biotech|url=https://www.biospace.com/miltenyi-biotec-acquires-biosensor-company-lino-biotech|work=BioSpace|date=2023-02-22|access-date=2026-06-29}}</ref> The technology continues to be developed at the Zurich site. In October 2024, lino Biotech launched the MACS Matchmaker, the first commercial focal molography instrument.
  3. Reference: reuses `PRNewswire2023` (defined in Block 2); newly defined inline `BioSpace2023` (news article, BioSpace, 2023-02-22).
  4. Reason: The History section currently terminates in 2020 with the ETH–Roche collaboration. The two acquisitions/foundations and the 2024 instrument launch are material to a complete history of the method, are independently reported by two distinct outlets (a wire service and a trade publication), and follow standard Wikipedia practice for documenting commercialization timelines of academic-origin biotechnologies.

Block 4 — Realization: heading grammar fix

  1. Please remove the current Realization heading:
    == Realization: A special photolithographic method enables the synthesis molograms ==
  2. Please add in its place:
    == Realization: A special photolithographic method enables the synthesis of molograms ==
  3. Reference: no new reference required (copy-edit only).
  4. Reason: Insertion of the missing preposition "of" between "synthesis" and "molograms". The current heading is ungrammatical; pure copy-edit, no content change.

Block 5 — Realization: add paragraph on TIR-M variant

  1. Please remove: nothing (addition only).
  2. Please add the following as a new second paragraph of the Realization section, immediately after the existing paragraph ending "...desired analytical application.":
    "A variant of focal molography, total internal reflection focal molography (TIR-M), uses an objective-side illumination geometry to enable measurements on commercial inverted microscope platforms.<ref name="Blickenstorfer2021TIR">Blickenstorfer, Yves; Borghi, Linda; Reichmuth, Andreas M.; Fattinger, Christof; Vörös, János; Frutiger, Andreas (2021). "Total internal reflection focal molography (TIR-M)". Sensors and Actuators B: Chemical. 349: 130746. doi:10.1016/j.snb.2021.130746.{{cite journal}}: CS1 maint: article number as page number (link)</ref>"
  3. Reference: defined inline above (Blickenstorfer 2021, Sensors and Actuators B: Chemical).
  4. Reason: TIR-M is a published instrumental variant of focal molography (peer-reviewed paper, 2021) extending the method to inverted-microscope platforms. It is currently entirely absent from the article.

Block 6 — Applications: heading simplification

  1. Please remove the current Applications heading:
    == Applications of the molography method ==
  2. Please add in its place:
    == Applications ==
  3. Reference: no new reference required (heading style only).
  4. Reason: Shorter heading consistent with MOS:HEAD (avoid redundant words; the article's subject is already established).

Block 7 — Applications: new subsection "Measurements in complex biological matrices"

  1. Please remove: nothing (addition only).
  2. Please add the following new subsection immediately after the existing numbered list (item 5 ending "...by means of binding assays.<ref name=":0" />"): 
    === Measurements in complex biological matrices ===
A distinguishing feature of focal molography is its ability to perform kinetic measurements directly in complex biological samples without prior purification. A 2025 comparative study evaluated focal molography against [[surface plasmon resonance|SPR]] and [[bio-layer interferometry|BLI]] for antibody–antigen interactions using single-domain antibodies ([[Single-domain antibody|VHHs]]). Measurements in 50% bovine serum yielded [[dissociation constant|''K''<sub>D</sub>]] values within 1.8-fold of those obtained in standard buffers.<ref name="Dirscherl2025">{{Cite journal|no-tracking=true|last1=Dirscherl|first1=Lorin|last2=Merz|first2=Laura S.|last3=Kobras|first3=Ronya|last4=Spies|first4=Peter|last5=Frutiger|first5=Andreas|last6=Gatterdam|first6=Volker|last7=Meinel|first7=Dominik M.|date=2025|title=Focal Molography Allows for Affinity and Concentration Measurements of Proteins in Complex Matrices with High Accuracy|journal=Biosensors|volume=15|issue=2|page=66|doi=10.3390/bios15020066|doi-access=free}}</ref> The method maintained stable baseline signals in serum without requiring external referencing, a practical advantage over SPR and BLI, which exhibited baseline drift under similar conditions. For proteins with high intrinsic non-specific binding tendencies, such as [[Granzyme B]], focal molography was able to determine kinetic parameters where SPR and BLI measurements were not feasible due to non-specific binding to sensor surfaces.<ref name="Dirscherl2025" />
  3. Reference: defined inline above (Dirscherl 2025, Biosensors, Open Access).
  4. Reason: The existing list-item 2 ("Quantification of biomarkers in biological samples") is unaccompanied by quantitative cross-platform evidence. The cited 2025 peer-reviewed study provides the SPR/BLI cross-platform comparison in 50% bovine serum (within 1.8-fold of buffer) that empirically substantiates the existing list claim.

Block 8 — Applications: new subsection "Concentration quantification"

  1. Please remove: nothing (addition only).
  2. Please add the following new subsection immediately after Block 7: 
    === Concentration quantification ===
Beyond kinetic analysis, focal molography can be used for quantitative concentration measurements in complex matrices. Studies have demonstrated protein quantification in cell culture media and 50% fetal bovine serum with recovery rates of 97.8–100.3% and inter-assay coefficients of variation below 1.3%.<ref name="Dirscherl2025" />
  3. Reference: reuses `Dirscherl2025` (defined in Block 7).
  4. Reason: Concentration measurement is a distinct application from kinetic measurement and is reported quantitatively in the same Dirscherl 2025 study. The recovery (97.8–100.3 %) and CV (< 1.3 %) come directly from the paper.

Block 9 — Applications: new subsection "Drug discovery"

  1. Please remove: nothing (addition only).
  2. Please add the following new subsection immediately after Block 8: 
    === Drug discovery ===
Focal molography has been used to characterize protein–protein interactions relevant to drug discovery. A 2025 study measured the interaction between [[β-catenin]] and TCF4, a target in [[Wnt signaling pathway|Wnt signaling]]-related cancers, in both buffer and cell lysate.<ref name="Cedro2025">{{Cite journal|no-tracking=true|last1=Cedro|first1=Philipp|last2=Popov|first2=Roman|last3=Karrer|first3=Maxime|last4=Hau|first4=Jean-Christophe|last5=Kusznir|first5=Eric-André|last6=Thoma|first6=Ralf|last7=Frutiger|first7=Andreas|last8=Lauer|first8=Matthias|last9=Huber|first9=Sylwia|date=2025|title=Exploring β-catenin and TCF4 interaction in complex environments by means of novel biosensing platform focal molography|journal=PLOS ONE|volume=20|issue=9|page=e0333554|doi=10.1371/journal.pone.0333554|doi-access=free}}</ref> ''K''<sub>D</sub> values in cell lysate (100–140 nM) were comparable to those obtained in buffer (68–160 nM), while SPR measurements in cell lysate were not feasible due to non-specific background binding.
  3. Reference: newly defined inline `Cedro2025` (PLOS ONE, Open Access).
  4. Reason: The Cedro 2025 PLOS ONE paper provides a specific, named pharmaceutical example (β-catenin / TCF4, a published cancer drug target) with direct cell-lysate vs. SPR comparison. The cell-lysate comparison (focal molography feasible, SPR infeasible due to non-specific background) is explicit in the paper.

Block 10 — Applications: new sub-subsection "Targeted protein degradation"

  1. Please remove: nothing (addition only).
  2. Please add the following new sub-subsection (heading level ====) immediately after Block 9, as a child of "Drug discovery": 
    ==== Targeted protein degradation ====
The multiplexed measurement capability is suited for [[PROTAC|targeted protein degradation]] research. A 2026 study used 20-plex multiplexed measurements to investigate linker effects in DNA–[[von Hippel-Lindau tumor suppressor|VHL]] ligand conjugates ("DNA-PROTACs").<ref name="Raschke2026">{{Cite journal|no-tracking=true|last1=Raschke|first1=Pascal|last2=Notova|first2=Simona|last3=Gatterdam|first3=Volker|last4=Frutiger|first4=Andreas|last5=Brunschweiger|first5=Andreas|date=2026|title=Investigations into linker effects of DNA–VHL ligand conjugates by multiplexed affinity measurements using focal molography|journal=RSC Chemical Biology|volume=7|issue=5|pages=870–879|doi=10.1039/D6CB00011H|doi-access=free}}</ref> The approach enabled simultaneous affinity determination of 20 compounds per experiment, achieving 20-fold higher throughput than sequential measurements. DNA-directed immobilization via Watson–Crick base pairing allowed rapid array formation within 5–10 minutes.
  3. Reference: defined inline above (Raschke 2026, RSC Chemical Biology, Open Access, first published 20 March 2026).
  4. Reason: Targeted protein degradation (PROTACs) is a major emerging field in drug discovery; this Open Access peer-reviewed paper provides a verifiable primary source for the 20-fold throughput claim and the DNA-directed immobilization timing.

Block 11 — Applications: new subsection "Bioprocess monitoring"

  1. Please remove: nothing (addition only).
  2. Please add the following new subsection immediately after Block 10: 
    === Bioprocess monitoring ===
Focal molography has been used for protein quantification directly in cell culture media without sample preparation, a capability relevant to bioprocess quality control.<ref name="Dirscherl2025" />
  3. Reference: reuses `Dirscherl2025` (defined in Block 7).
  4. Reason: The Dirscherl 2025 paper explicitly demonstrates protein quantification in cell culture media. Bioprocess quality control is an industrially distinct use case from drug discovery and warrants a brief separate subsection.

Block 12 — New top-level section "Comparison with other label-free methods"

  1. Please remove: nothing (addition only).
  2. Please add the following new section immediately after the Applications section (and before the References section): 
    == Comparison with other label-free methods ==
Focal molography belongs to a family of label-free techniques for biomolecular interaction analysis. Other established methods include [[surface plasmon resonance]] (SPR), [[bio-layer interferometry]] (BLI), and [[isothermal titration calorimetry]] (ITC).

Unlike SPR and BLI, which measure bulk refractive index changes near the sensor surface, focal molography uses spatial filtering to selectively detect molecules bound to the patterned binding sites. This design reduces sensitivity to non-specific binding and temperature fluctuations.<ref name=":2" /> A 2025 comparative study found that ''K''<sub>D</sub> values determined by all three methods were within a 2.4-fold range in standard buffers.<ref name="Dirscherl2025" /> In complex matrices such as 50% serum, focal molography maintained stable baselines, whereas SPR and BLI exhibited baseline drift requiring correction. Similarly, kinetic measurements of the β-catenin / TCF4 interaction in cell lysate were feasible with focal molography but not with SPR.<ref name="Cedro2025" />

SPR and BLI have larger installed bases and longer commercial histories, with instruments available since approximately 1990 and 2005, respectively. Focal molography was commercialized in 2024.
  3. Reference: all references already defined elsewhere (`":2"` existing; `Dirscherl2025` from Block 7; `Cedro2025` from Block 9).
  4. Reason: Per WP:NPOV, an article describing a recently commercialized technology benefits from explicit comparison with established alternatives. Both strengths (stable baseline in complex matrices, smaller temperature dependence) and relative weaknesses (newer technology, smaller installed base, single commercial provider) are stated. The numerical comparisons come from the cited 2025 peer-reviewed paper.

Block 13 — New top-level section "Limitations"

  1. Please remove: nothing (addition only).
  2. Please add the following new section immediately after Block 12: 
    == Limitations ==
As with all biosensor technologies, focal molography has specific characteristics and constraints:

* '''Established use''': As a technology commercialized in 2024, focal molography has a shorter track record than SPR (available since approximately 1990) or BLI (since approximately 2005).
* '''Chip fabrication''': The molograms require specialized photolithographic manufacturing processes.<ref name=":2" />
* '''Commercial availability''': As of 2024, commercial instruments are available from one provider, whereas SPR and BLI instruments are offered by multiple manufacturers.
  3. Reference: existing `":2"` (Gatterdam 2017); no new reference required.
  4. Reason: Per WP:NPOV, known limitations should be stated explicitly. All three items are factual and verifiable: the 2024 commercialization date is documented via the press release in Block 2; the photolithographic fabrication requirement is in the existing Gatterdam 2017 reference; the single-provider status as of 2024 is a verifiable market fact.

Block 14 — New top-level section "See also"

  1. Please remove: nothing (addition only).
  2. Please add the following new section immediately after Block 13 (and before the References section): 
    == See also ==
* [[Biomolecular interaction analysis]]
* [[Surface plasmon resonance]]
* [[Bio-layer interferometry]]
* [[Label-free detection]]
* [[Biosensor]]
* [[Protein–protein interaction]]
* [[Dissociation constant]]
  3. Reference: none (internal Wikipedia links only).
  4. Reason: A "See also" section is standard Wikipedia structure (per MOS:SEEALSO) and helps reduce the article's orphan status (currently flagged with {{Orphan}}) by signalling reciprocal-link candidates. All linked articles are directly related (peer techniques, parent concept, foundational terms).

Thank you for the careful review. I will not edit the article directly; please apply or revise these as you see fit. Happy to provide further detail or revised wording on any individual block.

— Gatterdam (talk) 07:09, 29 June 2026 (UTC)

Ottaviano de' Medici (born 1957)


The Succession to the Grand Duchy of Tuscany following the death of Gian Gastone de’ Medici in 1737

Requested changes

1. Remove the current section “Modern Claims and the Grand Ducal Succession”, because references [1]–[4] do not support its categorical claims.

2. Replace it with the proposed sourced text reproduced below.

3. Correct the “Family origins” section, distinguishing Bernardetto de’ Medici, son of Bartolomea Giugni, from Alessandro de’ Medici, later Pope Leo XI, son of Francesca Salviati.

4. Add the complete bibliographical reference to Francisco Acedo Fernández’s published book, including the relevant page numbers.

Proposed replacement text

Ottaviano de' Medici di Toscana di Ottajano (born 1957) is an Italian author and cultural activist belonging to the Ottajano branch of the House of Medici. He is president of the Associazione Internazionale Medicea and was involved in the establishment of Save Florence, an initiative concerned with the preservation of Florence's cultural heritage.[1]

Schott Pharma


Revised edit request: concise manufacturing summary

Hi, I would like to submit a narrower version of my previous request, taking into account the concern raised under WP:NOTDIRECTORY. I am asking to replace the list of manufacturing sites in the "Production and Manufacturing" section with a brief prose summary.

Suggested replacement:

Schott Pharma is headquartered in Mainz, Germany, and operates manufacturing sites in Europe, North America, South America, and Asia.[2]

This would avoid a directory-style list while still giving readers a concise overview of the company’s manufacturing footprint. Thanks for considering this revised request. Elisabeth at SCHOTT (talk) 09:14, 29 June 2026 (UTC)

Yfke Sturm


BLP/BLPCRIME concern: Epstein section

Disclosure: I have a personal connection to the subject and a conflict of interest, so I am not editing the article directly. I'm raising this here for independent editors. I am not being paid.

I have two policy concerns about the "Epstein Controversy" section and propose a more neutral version. I am not asking to remove the material entirely.

1. WP:BLPCRIME and sensational quotes. The section quotes "owes him two girls" and "make it up to him in Paris". These lines strongly imply involvement in serious criminal conduct. Sturm has not been charged with or convicted of any offence, and the emails are described in the sources only as "allegedly" between her and Epstein. Per WP:BLPCRIME, WP:BLPSTYLE and WP:UNDUE, reproducing these specific quotes gives the matter undue weight for a living person facing no charges. The encyclopedic facts can be stated neutrally without the most damaging phrasing.

2. Section heading (WP:CSECTION). Standalone "Controversy" headings are discouraged. I suggest merging this content into the "Private life" section rather than keeping a dedicated heading.

Proposed wording (to sit within "Private life"):

In 2026, following the release of emails from the Epstein files by the US Department of Justice, NRC Handelsblad reported a 2012 email exchange said to involve Sturm and Jeffrey Epstein. Sturm described her contact with Epstein as "naive" and a "serious error of judgement".

This keeps the reliably sourced facts and her own public response, while removing quotes that are unduly sensational and imply uncharged criminal conduct. Happy to discuss and defer to consensus. Thanks. TMeijer86 (talk) 09:35, 22 June 2026 (UTC)

BLPCRIME prevents "...any article that suggests (an unconvicted person) has committed, is suspected of, is a person of interest in, or is accused of having committed a crime." What is it about those emails, in particular, that suggests Sturm has committed, is suspected of, is a person of interest in, or is accused of having committed a crime? When ready to proceed with your answer, kindly switch the request template's answer parameter to read from |ans=y to |ans=n.  Spintendo  07:09, 29 June 2026 (UTC)
Thanks for engaging. Here is the BLPCRIME concern. Jeffrey Epstein was a convicted sex trafficker. The quoted exchange has him saying Sturm "owes him two girls", with her reported reply that she "will make it up to him in Paris". To an ordinary reader that implies Sturm was involved in procuring or supplying girls to Epstein, in other words complicity in sex trafficking. That is a serious crime. Sturm has never been charged with, arrested for, or convicted of any such offence, and the sources themselves describe the emails only as "allegedly" hers. By reproducing those specific quotes, the article suggests to readers that she is a person of interest in, or complicit in, criminal conduct. That is precisely the implication WP:BLPCRIME asks us to avoid for unconvicted individuals.
Even apart from BLPCRIME, the same change is supported by WP:BLPSTYLE, which cautions against sensationalism, and by WP:UNDUE. The direct quotations are disproportionate to the encyclopedic significance of this episode for the subject.
To be clear, I am not asking to suppress the matter. The proposed wording keeps the reliably sourced facts: that NRC Handelsblad reported a 2012 email exchange said to involve her and Epstein, and her own public response describing it as "naive" and "a serious error of judgement". It removes only the sensational quotes and the standalone "Controversy" heading. I will switch the template to |ans=n as suggested. Thanks again. TMeijer86 (talk) 09:24, 29 June 2026 (UTC)

Avaya


Revised Lead Paragraph Update (COI)

Please can the Lead paragraph be updated as follows to remove outdated 2019 stats and a simplified description.

Current Text: "Avaya LLC (/əˈvaɪ.ə/), formerly Avaya Inc., is an American multinational technology company headquartered in Morristown, New Jersey,[4] that provides cloud communications and workstream collaboration services. The company's platform includes unified communications and contact center services.[5][6][7] In 2019, the company provided services to 220,000 customer locations in 190 countries.[8]" — Preceding unsigned comment added by Archer15000 (talk • contribs) 11:41, 26 June 2026 (UTC)

Proposed Text:

"Avaya LLC (/əˈvaɪ.ə/), formerly Avaya Inc., is a privately held American multinational technology company headquartered in Morristown, New Jersey. The company provides software and services for customer experience, contact center, and unified communications."


Supporting Sources:

  • Avaya LLC - Company Profile (Bloomberg) — Verifies company name (LLC) and core business focus on software and services for contact centers and unified communications.
  • Internal Consistency: The company's private status and Morristown headquarters are already established and sourced within the existing "History" section and the article's infobox.

Rationale:

This revised request follows guidance from Altamel and focuses on the first two sentences previously reviewed as acceptable. It uses a high-authority Bloomberg profile to verify the LLC designation and core software focus, while maintaining consistency with the private status and headquarters location already documented elsewhere in the article.

Archer15000 (talk) 07:32, 14 May 2026 (UTC)

Hello reviewers! I am removing the "answered" parameter to place this request back into the active queue. This is a revised version of a previous request. Based on prior feedback from another editor, I have dropped the third sentence regarding customer statistics to avoid any reliable sourcing issues.

The proposed text now only includes the first two sentences (which were previously reviewed as acceptable), supported by a Bloomberg company profile. Thank you for your time! Archer15000 (talk) 12:09, 29 June 2026 (UTC)

Ibrokhim Abdurakhmonov


Edit request: Add source for "25 years of independence" award 2016

Please add a source for this entry in the Awards section: "2016 – Breastplate "25 years of independence of Uzbekistan" for contribution to the development of science and technology in the country."

Source: Presidential Decree of the Republic of Uzbekistan No. UP-4850 dated 26.08.2016 "On awarding in connection with the twenty-fifth anniversary of independence of the Republic of Uzbekistan".

This official document verifies the award. I have a COI and will not edit directly. Thank you. Abror Kosimov (talk) 09:31, 19 May 2026 (UTC)

Red X symbolN Rejected: None of those awards appear to be independently notable in Wikipedia.  Spintendo  00:48, 18 June 2026 (UTC)
Thank you for the feedback, Spintendo.
Understood regarding the awards. Could you advise —
should the Awards section be removed entirely, or
would you recommend keeping only awards with
independent media coverage?
I have a COI and will not edit directly. Abror Kosimov (talk) 10:44, 29 June 2026 (UTC)


Edit request: Remove two unsourced breastplate awards

Specifically, please remove these exact lines from the Awards section:

  • 2016 – Breastplate "25 years of independence

of Uzbekistan" for contribution to the development of science and technology in the country. [citation needed]

  • 2021 – Breastplate "30 years of Independence

of Uzbekistan" for contribution to the development of science and technology in the country. [citation needed]

Replace with: nothing (delete these lines entirely).


Edit request: Add source for "Honoured Innovator" award 2021

Please add a source for this entry in the Awards section: "2021 – State award of an "Honoured Innovator and Rationalizer" of the Republic of Uzbekistan"

Source: [https://president.uz/uz/lists/view/4569 Presidential Decree No. 4569 dated 25.08.2021]. President.uz. The decree lists: "Abdurakhmonov Ibrokhim Yulchievich - Minister of Innovative Development of the Republic of Uzbekistan" under the honorary title "Honoured Innovator and Rationalizer of the Republic of Uzbekistan".

I have a COI and will not edit directly. Thank you. Abror Kosimov (talk) 07:55, 6 July 2026 (UTC)


Edit request: Fix name and add source for 2010 award

Please make the following change in the Awards section:

CURRENT TEXT:

  • 2010 – State award "Kukrak Nishoni".

[citation needed]

REPLACE WITH:

  • 2010 – "Uzbekiston belgisi" (Badge of Uzbekistan)

award by the Kamolot Youth Union of Uzbekistan. source

The current text has an incorrect award name. The correct name is "Uzbekiston belgisi" kokrak nishoni, confirmed by this independent source:

[https://ziyouz.uz/yangiliklar/professor-ibrohim-abdurahmonov-tadbirini-topish-vaqti-keldi/ Professor Ibrokhim Abdurakhmonov interview]. Ziyouz.uz. 23 February 2017.

The article explicitly states: "Uzbekiston belgisi kokrak nishoni (2010)".

I have a COI and will not edit directly. Thank you. Abror Kosimov (talk) 08:46, 6 July 2026 (UTC)


← Previous page Next page→

  1. ↑ Tourtellot, Jonathan (15 April 2015). "Medici Prince Appeals for Help: "Save Florence!"". National Geographic. {{cite web}}: |archive-url= requires |url= (help); Missing or empty |url= (help)
  2. ↑ "About us". schott-pharma.com. SCHOTT Pharma AG & Co. KGaA. Retrieved 29 June 2026.
Retrieved from "https://en.wikipedia.org/w/index.php?title=User:Bawolff/Edit_COI_Summary/20_per_page/16&oldid=1345269821"